Haw Par Corporation Ltd
SGX:H02
Haw Par Corporation Ltd
SGX:H02
Price:
9.64 SGD
-2.13%
Market Closed
Updated:
May 4, 2024
Haw Par Corporation Ltd
Net Income (Common)
|
Haw Par Corporation Ltd
Net Income (Common) Peer Comparison
Comparables:
WVE
H
1J5
I
42C
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Net Income (Common)
S$216.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Net Income (Common)
-$57.5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Net Income (Common)
S$8.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Net Income (Common)
-S$9.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is Haw Par Corporation Ltd's Net Income (Common)?
Net Income (Common)
216.6m
SGD
216.6m
SGD
Based on the financial report for Dec 31, 2023, Haw Par Corporation Ltd's Net Income (Common) amounts to 216.6m SGD.
What is Haw Par Corporation Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%
7%
Over the last year, the Net Income (Common) growth was 46%. The average annual Net Income (Common) growth rates for Haw Par Corporation Ltd have been 22% over the past three years , 4% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
